1.Surgical treatment of ruptured aneruysm of the sinus of valsalva.
Eung Joong KIM ; Suk Ha HWANG ; Jin Seog PARK
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(6):488-491
No abstract available.
Sinus of Valsalva*
2.Surgical treatment of the abdominal aortic aneurysm.
Suk Ha HWANG ; Eung Joong KIM ; Seung Pyung LIM ; Jang Soo HONG ; Young LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(5):355-359
No abstract available.
Aortic Aneurysm, Abdominal*
3.Genetic Variation of HUMACTBP2 Locus Detected by Fluorescent-based Typing in the Korean Population and its Forensic.
Ha Joo CHOI ; Hae Lin LEE ; Yong Suk NAM ; Juck Joon HWANG ; Gil Ro HAN
Korean Journal of Legal Medicine 1997;21(1):41-58
The HUMACTBP2 locus was investigated to collect population genetic data in the Korean population and to evaluate the applicability for the forensic field. An Automatic fluorescent-based sequencer (377 automatic DNA sequencer, ABI) was used to detect amplified fragments of the HUMACTBP2 locus electrophoresed on 4% denaturing polyacrylamide sequencing gels. ACTBP2 allelic ladder consisting of different sizes of 18 alleles was constructed and employed as an internal size standard in combination with a GS-350 size standard for precision of allele-band sizing. By utilizing different fluorescent dyes, both the allelic ladders and samples were able to be analyzed in the same lane by 99% orecision of allele-band sizing. Among the Korean population (n=224), 26 alleles in the range of 239-313 bp are determined. allele No. 6 is found 45 times (0.100) which is mostly frequent, and the rest of allele is distributed with their relative frequency of 0.002-0.100. The comparison between observed and expected numbers of homozygous and heterozygous individuals confirms that ACTBP2 locus is in the state of Hardy-Weinberg equilibrium among the Korean population. The heterozygosity is 0.9389+/-0.0034(93.89%), and the power of discrimination(PD) and power of exclusion(PEX) are calculated to be 0.991(99.1%)and 0.890(89.0%), respectively, showing the high informativeness for individual identification. Thus, these results mean that the HUMACTBP2 locus can effectively be used for the forensic application.
Alleles
;
DNA
;
Fluorescent Dyes
;
Gels
;
Genetic Variation*
4.Change of CK-MB in OHS by using of different cardioplegia.
Suk Ha HWANG ; Eung Joong KIM ; Seung Pyung LIM ; Young LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(12):899-903
No abstract available.
Heart Arrest, Induced*
5.Surgical management of post-AMI VSD: a case report.
Suk Ha HWANG ; Eung Joong KIM ; Seung Pyung LIM ; Young LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1992;25(4):424-428
No abstract available.
6.MRI of osteonecrosis of the femoral head : Diagnostic value and histologic correlation.
Chang Soo KANG ; Byung Woo MN ; Sung Ha LEE ; Suk Young HWANG
The Journal of the Korean Orthopaedic Association 1993;28(2):527-539
No abstract available.
Head*
;
Magnetic Resonance Imaging*
;
Osteonecrosis*
7.The Therapeutic Effect of Postganglionic Nerve Block for Symptomatic Schmorl Nodule: A Retrospective Case Series
In Seok SON ; Suk Hyun HWANG ; Suk Ha LEE ; Min Seok KANG
Journal of Korean Society of Spine Surgery 2018;25(4):147-153
STUDY DESIGN: Retrospective case series. OBJECTIVES: We retrospectively evaluated the clinical efficacy of postganglionic nerve block in symptomatic Schmorl nodules (SNs). SUMMARY OF LITERATURE REVIEW: SNs are common lesions that are often asymptomatic. In certain cases, SNs have been reported to cause severe axial back pain, thereby considerably impacting patients' quality of life. No consensus currently exists on the treatment of symptomatic SNs. MATERIALS AND METHODS: From October 2015 to October 2017, a total of 21 patients with symptomatic SNs diagnosed by magnetic resonance imaging (MRI) that did not respond to conservative treatment after 4 weeks were included in the study. All patients received postganglionic nerve block. We evaluated effective pain relief (improvement of back pain of more than 50% compared with before the intervention) and functional improvements, assessed by visual analogue scale (VAS) and Oswestry Disability Index scores obtained at 4 hours, 4 weeks, 8 weeks, 3 months, and 6 months after the procedure. RESULTS: Symptomatic SNs were more common at the L2-3 level, and the lower end plate was more commonly involved than the upper end plate. Eighteen of the 21 patients (85.7%) showed effective pain relief, and no deterioration was observed within the follow-up period. Throughout the follow-up period, the VAS remained significantly improved compared to before the procedure (p < 0.05). Complications were not reported in any cases. CONCLUSIONS: Postganglionic nerve block for symptomatic SNs that do not respond to conservative treatment is a non-invasive modality for pain relief.
Back Pain
;
Consensus
;
Follow-Up Studies
;
Humans
;
Magnetic Resonance Imaging
;
Nerve Block
;
Quality of Life
;
Retrospective Studies
;
Treatment Outcome
8.The Therapeutic Effect of Postganglionic Nerve Block for Symptomatic Schmorl Nodule: A Retrospective Case Series
In Seok SON ; Suk Hyun HWANG ; Suk Ha LEE ; Min Seok KANG
Journal of Korean Society of Spine Surgery 2018;25(4):147-153
OBJECTIVES:
We retrospectively evaluated the clinical efficacy of postganglionic nerve block in symptomatic Schmorl nodules (SNs).SUMMARY OF LITERATURE REVIEW: SNs are common lesions that are often asymptomatic. In certain cases, SNs have been reported to cause severe axial back pain, thereby considerably impacting patients' quality of life. No consensus currently exists on the treatment of symptomatic SNs.
MATERIALS AND METHODS:
From October 2015 to October 2017, a total of 21 patients with symptomatic SNs diagnosed by magnetic resonance imaging (MRI) that did not respond to conservative treatment after 4 weeks were included in the study. All patients received postganglionic nerve block. We evaluated effective pain relief (improvement of back pain of more than 50% compared with before the intervention) and functional improvements, assessed by visual analogue scale (VAS) and Oswestry Disability Index scores obtained at 4 hours, 4 weeks, 8 weeks, 3 months, and 6 months after the procedure.
RESULTS:
Symptomatic SNs were more common at the L2-3 level, and the lower end plate was more commonly involved than the upper end plate. Eighteen of the 21 patients (85.7%) showed effective pain relief, and no deterioration was observed within the follow-up period. Throughout the follow-up period, the VAS remained significantly improved compared to before the procedure (p < 0.05). Complications were not reported in any cases.
CONCLUSIONS
Postganglionic nerve block for symptomatic SNs that do not respond to conservative treatment is a non-invasive modality for pain relief.
9.Early and late results after mitral valve replacement.
Myung In KIM ; Suk Ha HWANG ; Woong Chul YOO ; Eung Joong KIM ; Seung Pyung LIM ; Young LEE ; Jang Soo HONG
The Korean Journal of Thoracic and Cardiovascular Surgery 1992;25(2):149-157
No abstract available.
Mitral Valve*
10.Prediction of Prognosis by Acetazolamide Brain Perfusion SPECT in Patients with Arteriovenous Malformation.
Sang Gyun BAE ; Jae Gon MOON ; Suk Mo LEE ; Han Gyu KIM ; Ha Yong YEOM ; Do Yoon HWANG
Korean Journal of Nuclear Medicine 2000;34(5):426-432
After surgical operation in patients with arteriovenous malformation (AVM), normal pressure perfusion breakthrough (NPPB) is one of the major complications. Brain perfusion SPECT with acetazolamide stress was known to be useful to evaluate the vascular reserve in several neurological and neurosurgical conditions. The authors performed acetazolamide brain perfusion SPECT in patients with AVM and compared the brain perfusion in the post-operative clinical courses. The acetazolamide brain perfusion SPECT was helpful in defining the prognosis of the patients with AVM. We describe 4 patients with AVM who had acetazolamide brain perfusion SPECT to examine the prognosis.
Acetazolamide*
;
Arteriovenous Malformations*
;
Brain*
;
Humans
;
Perfusion*
;
Prognosis*
;
Technetium Tc 99m Exametazime
;
Tomography, Emission-Computed, Single-Photon*